MedTrace Logo

An Evaluation of the Effectiveness of Dual Focus Soft Contact Lenses in Slowing Mypoia Progression

NCT01729208 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 144

Last updated 2020-02-24

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine whether a new type of soft contact lens with a unique optical design (dual focus) is effective at slowing the progression of myopia (near-sightedness) in children.

Conditions

  • Myopia

Interventions

DEVICE

Dual Focus Soft Contact Lens

DEVICE

Single Vision Soft Contact Lens

Sponsors & Collaborators

  • Visioncare Research Ltd.

    collaborator OTHER

  • CooperVision, Inc.

    lead INDUSTRY

Principal Investigators

  • José Manuel González-Méijome · University of Minho

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
8 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2017-05-31
Completion
2019-05-31
FDA Device
Yes

Countries

  • Canada
  • Portugal
  • Singapore
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01729208 on ClinicalTrials.gov